2023Background: The Global COVID Vaccine Safety (GCoVS) project was established in 2021 under the multinational Global Vaccine Data Network (GVDN) consortium to facilitate the rapid assessment of the safety of newly introduced vaccines. This study analyzed data from GVDN member sites on the back...
Researchers from a number of research institutions around the world are studying the new coronavirus, hoping to develop a vaccine that can be used in clinical trials in the short term. On January 10, Chinese scientists released the genetic makeup of the new coronavirus to a public database, t...
UNITED NATIONS, April 25 (Xinhua) -- Two UN agencies alongside the Bill and Melinda Gates Foundation and the global vaccine alliance Gavi launched a collaborative campaign on Wednesday to boost global vaccination programs, marking the beginning of World Immunization Week. The campaign, called Humanly...
vaccine would be used. A DNA vaccine against a microbe would evoke a strong antibody response to thefree-floating antigensecreted by cells, and the vaccine also would stimulate a strong cellular response against the microbial antigens displayed on cell surfaces. TheDNA vaccinecouldn’t cause the ...
quadrivalent influenza vaccine SMTA2 Standard Material Transfer Agreements 2 TIV trivalent influenza vaccine VLP virus-like particle 2. Methods 2.1. Methods for gathering information WHO maintains a database of influenza vaccine manufacturers, including information on vaccine type, formulation and substrate ...
of the individual probabilities) in a publication compared with a pair of topics each related to a different fields of study. By making this assumption, we can look at the co-occurrence network of the topics, as uncovered by LDA, to find fields of research within our publication data set....
Figure 2 summarizes the results of a set of global vaccine-distribution scenarios with a focus on the results under the combination of “Oldest First” and “High risk” scenarios. The results under other scenario combinations are documented in Supplementary Figs. 2–5 and Supplementary Data 2–...
Pfizer Inc. (NYSE: PFE) announced today the launch of its Vaccines Division's Centers of Excellence Network, a global program of collaborations with academic institutions to conduct real-world epidemiologic research to accurately identify and measure the burden of specific vaccine-preventable diseases ...
when and how to meeting global demand for vaccines. This study addresses these research gaps. Using data on R&D investments, global regulatory approvals, manufacturing and purchase agreements, and vaccine deliveries, we identify six distinct innovation models that cover the 14 COVID-19 vaccines with...
The study investigates the global impact of land property rights on land use efficiency (LUE), as measured by the key indicator for United Nations Sustainable Development Goal 11.3.1, namely Land Consumption Rate to Population Growth Rate. By utilizing human-land change data from 165 countries spa...